Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize that magnesium sulphate owing to its analgesic and sedative properties is not inferior to fentanyl in providing conscious sedation as adjuvants to propofol and local injection of lidocaine in patients undergoing surgery for evacuation of subdural haematoma. Consequently, the investigators are testing this hypothesis by comparing the sedative and analgesic effects of magnesium sulphate versus fentanyl as adjuvants to propofol lidocaine admixture for conscious sedation in patients undergoing burr hole surgery for evacuation of subdural haematoma.


Clinical Trial Description

Following institutional ethical committee approval, 34 patients undergoing burr-hole surgery for chronic subdural hemorrhage were included in this prospective, randomized, double-blind study.

Written informed consent were obtained from all subjects before enrollment in the study.

During the preanesthetic checkup,the operative procedure and anesthetic techniques were explained to all patients.

Upon arrival to operating theater, standard monitoring were applied to all patients and bispectral index was applied before starting the drug infusions and was used for maintenance of sedation during operation.

Subjects were randomized into 2 groups. Magnesium (M) group received Magnesium sulphate 50mg/kg IV over 15 minutes Followed by continuous infusion at 15 mg/kg/h Fentanyl (F) group received fentanyl 1 μg /kg IV bolus over 15 minutes Followed by continuous infusion starting at 0.5 μg /kg/h Loading and infusion doses of magnesium sulphate and loading doses of fentanyl were chosen from previous studies.

In both groups fentanyl and magnesium sulphate were accompanied by IV propofol at a dose of 50- 150 μg /kg/min bolus over 10 minutes to achieve target sedation level, that is, Ramsay sedation scale (RSS) 3, if RSS afterwards does not reach 3, a supplementary bolus dose of 0.2 mg/kg propofol were given to the patients, followed by ( 20-40 μg /kg/ min) to maintain Intraoperative level of sedation by bispectral index (BIS ) reading by 60-80 After achieving predefined target sedation level (RSS of 3), surgeons infiltrated the sites of the burrholes with 20 mL of a local anesthetic solution containing 10 mL of 0.5% bupivacaine and 10 mL of 2% lidocaine with adrenaline infiltrated locally at least 5 minutes before surgical incision. After burr-hole craniotomy followed by the hematoma evacuation is accomplished, the Infusion of sedatives were discontinued just after placement of the final skin suture.

Intraoperative patient's movement is defined as those likely to interfere with surgical procedure such as bending of hand and/or leg and movement of head were recorded. The first intervention is to attempt patient reassurance for 30 seconds. If movement continues then the bolus dose of propofol of 0.5 mg/kg was given and infusion dose was increased in the previously described manner till the maximum dose to regain BIS sedation score between 60-80.

If the patient starts to move again the same sequence was repeated. Induction of general anesthesia was deemed the final intervention in case satisfactory condition was not achieved within the rescue propofol.

All patients were transferred to the post-anesthesia care unit (PACU) after surgery.

The data collected are:

1. Total amount of Propofol consumption.

2. Total number of patient movements

3. The intraoperative and postoperative hemodynamic data

4. VAS (Visual analogue scale for pain) score

5. Time to first rescue analgesic

6. Adverse events

7. Surgeon satisfaction score was recorded.

Statistical analysis:

Data was analyzed using SPSS © Statistics version 23 (IBM© Corp., Armonk, NY, USA). Chi-square test (Fisher's exact test) was used to examine the relation between qualitative variables. For quantitative data, comparison between the two groups was done using independent sample t-test or Mann-Whitney test as appropriate. All tests were two-tailed. A p-value < 0.05 was considered significant.

Sample Size calculation:

A previous study reported that pre-procedure magnesium sulphate reduced the total propofol requirements to 130±19.09 mg compared to 172.8±29.09 mg with pre-procedure fentanyl. Based on these results, a sample size of 15 cases in each group was satisfactory to elicit the difference at an alpha level of 0.05 and a power of the test of 95%. The sample size was increased to 17 per group to compensate for possible dropouts. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03548493
Study type Interventional
Source Kasr El Aini Hospital
Contact
Status Completed
Phase Phase 2
Start date April 10, 2018
Completion date August 9, 2018

See also
  Status Clinical Trial Phase
Terminated NCT02573818 - Sedasys Post Approval Study Users Response to System Alarms N/A
Recruiting NCT01100554 - Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy N/A
Terminated NCT00226785 - Dexmedetomidine for Continuous Sedation Phase 3
Completed NCT02518919 - Procedural Sedation And Analgesia in Children in the Emergency Department: The Role of Adjunct Therapies N/A
Enrolling by invitation NCT04172415 - Current Procedural Sedation Practices in a Canadian Community Emergency Department
Completed NCT01020643 - Closed-loop Sedation of Propofol for Patients Undergoing Spinal Anesthesia Phase 4
Completed NCT00318955 - Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients Phase 4
Completed NCT04621526 - Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma Phase 1/Phase 2
Completed NCT03085563 - A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department Phase 4
Completed NCT01873612 - Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers Phase 4
Not yet recruiting NCT03466242 - IN Dexmedetomidine for Procedural Sedation in Pediatric Closed Reductions for Distal Forearm Fractures Early Phase 1
Completed NCT02679781 - Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care N/A
Completed NCT03885427 - Analgo-Sedative Effects Of Oral, Or Nebulized Ketamine In Pre-schoolers Undergoing Elective Surgery. Early Phase 1
Completed NCT00452426 - Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy Phase 3
Completed NCT00261599 - An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy Phase 3
Completed NCT00641563 - Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG) N/A
Active, not recruiting NCT01118884 - Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children Phase 3
Terminated NCT00809380 - Parental Presence During Fracture Reduction in Children at the Emergency Department; A Randomized Controlled Trial N/A
Completed NCT03886454 - Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
Completed NCT03925779 - Conscious Sedation for Outpatient Colonoscopy Phase 2